Page 1 | Search Results | Blood | American Society of Hematology

Skip Nav Destination

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Impact of statin use on outcomes in chronic lymphocytic leukemia patients receiving ibrutinib therapy: A real-world study

Lay She Ng, Alice He, Yone Phar Lin, Daniel Roque, Glennis Cho, Wern Lynn NG, Oksana Karpov, Utpal Dave

Blood (2025) 146 (Supplement 1): 2717.

https://doi.org/10.1182/blood-2025-2717

Published: 2025

Journal Articles

Adverse event profiles of acalabrutinib and zanubrutinib in chronic lymphocytic leukemia: A real-world comparison

Lay She Ng, Alice He, Yone Phar Lin, Vyom Patel, Martin Cuevas, Wern Lynn NG, Oksana Karpov, Utpal Dave

Blood (2025) 146 (Supplement 1): 7419.

https://doi.org/10.1182/blood-2025-7419

Published: 2025

Journal Articles

Risk of second primary malignancy following chimeric antigen receptor T-cell therapy: A real-world cohort study

Lay She Ng, Ashtyn Phillippi, Anna Homeniuk, Yone Phar Lin, Wern Lynn NG, Oksana Karpov, Hongtao Liu

Blood (2025) 146 (Supplement 1): 7667.

https://doi.org/10.1182/blood-2025-7667

Published: 2025

Journal Articles

Risk of second primary malignancies in patients with chronic lymphocytic leukemia treated with zanubrutinib and acalabrutinib: A real-world data analysis

Lay She Ng, Yone Phar Lin, Ashtyn Phillippi, Martin Cuevas, Glennis Cho, Wern Lynn NG, Oksana Karpov, Utpal Dave

Blood (2025) 146 (Supplement 1): 7430.

https://doi.org/10.1182/blood-2025-7430

Published: 2025

Journal Articles

Impact of autoimmune disease on clinical outcomes in patients undergoing CAR T-cell therapy: A real-world analysis

Lay She Ng, Yone Phar Lin, Maryam Habib, Wern Lynn NG, Oksana Karpov, Hongtao Liu

Blood (2025) 146 (Supplement 1): 7672.

https://doi.org/10.1182/blood-2025-7672

Published: 2025

Journal Articles

Assessment of the Expression of Genes Related to Epigenetic and Chromatin Modifications in Diffuse Large B-Cell Lymphoma Patients Resistant to R-CHOP

Wern Lynn NG, Evelyn Calderon-Martinez, Lay She Ng, Lillian Sangha, Chandi Garg, Iuliia Kovalenko, Christian Zevallos-Delgado

Blood (2023) 142 (Supplement 1): 6094.

https://doi.org/10.1182/blood-2023-180349

Published: 2023

Journal Articles

Tyrosine Kinase Inhibitors in the Treatment of Steroid Refractory Chronic Graft Versus Host Disease

Tabinda Saleem, Iuliia Kovalenko, Babray Laek, Rimsha Ali, Taaha Muddassir Mirza, Asmi Chattaraj, Ahsan Wahab, Asma Tameez, Hafiz Qurashi, Konstantin Golubykh, Martin Cuevas, Wern Lynn Ng, Yijin Wert, Rafiullah Khan

Blood (2022) 140 (Supplement 1): 12898–12899.

https://doi.org/10.1182/blood-2022-157632

Published: 2022

Journal Articles

Novel Drugs in the Treatment of Steroid Refractory Acute Graft Versus Host Disease

Iuliia Kovalenko, Tabinda Saleem, Babray Laek, Rimsha Ali, Taaha Mirza, Asmi Chattaraj, Ahsan Wahab, Asma Tameez, Hafiz Qurashi, Konstantin Golubykh, Martin Cuevas, Wern Lynn Ng, Yijin Wert, Rafiullah Khan

Blood (2022) 140 (Supplement 1): 12895–12896.

https://doi.org/10.1182/blood-2022-157624

Published: 2022

Journal Articles

Outcomes with Immunochemotherapy Plus Radiation Versus Immunochemotherapy Alone in Stage I Diffuse Large B-Cell Lymphoma: A Retrospective Study

Wern Lynn Ng, Allison M. Bock, Iuliia Kovalenko, Yijin Wert, Lay She Ng, Yucai Wang, Grzegorz S. Nowakowski

Blood (2022) 140 (Supplement 1): 3829–3830.

https://doi.org/10.1182/blood-2022-171148

Published: 2022

Journal Articles

A Multi-Center Study: Outcomes Among Relapsed/Refractory Diffuse Large B Cell Lymphoma Patients with CD20 Loss

Radhika Takiar, Wern Lynn Ng, Eshana Shah, Philip S. Boonstra, Yasmin H. Karimi, Shannon A. Carty, Ryan A. Wilcox, Carlos A. Murga Zamalloa, Grzegorz S. Nowakowski, Tycel J. Phillips

Blood (2022) 140 (Supplement 1): 9510–9511.

https://doi.org/10.1182/blood-2022-158825

Published: 2022

Update search

NARROW

Publications

Format

Article Type

Date

Availability

Impact of statin use on outcomes in chronic lymphocytic leukemia patients receiving ibrutinib therapy: A real-world study

Adverse event profiles of acalabrutinib and zanubrutinib in chronic lymphocytic leukemia: A real-world comparison

Risk of second primary malignancy following chimeric antigen receptor T-cell therapy: A real-world cohort study

Risk of second primary malignancies in patients with chronic lymphocytic leukemia treated with zanubrutinib and acalabrutinib: A real-world data analysis

Impact of autoimmune disease on clinical outcomes in patients undergoing CAR T-cell therapy: A real-world analysis

Assessment of the Expression of Genes Related to Epigenetic and Chromatin Modifications in Diffuse Large B-Cell Lymphoma Patients Resistant to R-CHOP

Tyrosine Kinase Inhibitors in the Treatment of Steroid Refractory Chronic Graft Versus Host Disease

Novel Drugs in the Treatment of Steroid Refractory Acute Graft Versus Host Disease

Outcomes with Immunochemotherapy Plus Radiation Versus Immunochemotherapy Alone in Stage I Diffuse Large B-Cell Lymphoma: A Retrospective Study

A Multi-Center Study: Outcomes Among Relapsed/Refractory Diffuse Large B Cell Lymphoma Patients with CD20 Loss

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only